Replies to post #3139 on Radient Pharmaceuticals Corporation fka RXPC

[Pharaoh-1]

According to Douglas MacLellan, Executive Chairman and CEO of Radient Pharmaceuticals, "We are honored to have someone with Dr. Rooks' track record join RPC's Board of Directors and anticipate he will provide valuable contributions to the Company in regards to RPC's anticipated introduction of our Onko-Sure® cancer test into the veterinary market."

http://finance.yahoo.com/news/Radient-Pharmaceuticals-iw-1172444324.html?x=0&.v=1